Literature DB >> 25027833

Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.

Edda Haberlandt1, Sibylle Zotter, Martina Witsch-Baumgartner, Johannes Zschocke, Dieter Kotzot.   

Abstract

UNLABELLED: Fragile X syndrome characterized by intellectual disability (ID), facial dysmorphism, and postpubertal macroorchidism is the most common monogenic cause of ID. It is typically induced by an expansion of a CGG repeat in the fragile X mental retardation 1 (FMR1) gene on Xq27 to more than 200 repeats. Only rarely patients have atypical mutations in the FMR1 gene such as point mutations, deletions, or unmethylated/partially methylated full mutations. Most of these patients show a minor phenotype or even appear clinically healthy. Here, we report the dysmorphism and clinical features of a 17-year-old boy with a partially methylated full mutation of approximately 250 repeats. Diagnosis was made subsequently to the evaluation of a FMR1 premutation as the cause for maternal premature ovarian failure. Dysmorphic evaluation revealed no strikingly long face, no prominent forehead/frontal bossing, no prominent mandible, no macroorchidism, and a head circumference in the lower normal range. Acquisition of a driving license for mopeds and unaccompanied rides by public transport in his home province indicate rather mild ID (IQ = 58).
CONCLUSION: This adolescent demonstrates that apart from only minor ID, patients with a partially methylated FMR1 full mutation present less to absent pathognomonic facial dysmorphism, thus emphasizing the impact of family history for a straightforward clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027833     DOI: 10.1007/s00431-014-2375-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

Review 1.  Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  D J Michelson; M I Shevell; E H Sherr; J B Moeschler; A L Gropman; S Ashwal
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

2.  Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.

Authors:  Mallikarjuna R Guruju; K Lavanya; B K Thelma; M Sujatha; V R OmSai; V Nagarathna; P Amarjyothi; A Jyothi; M P J S Anandaraj
Journal:  J Clin Neurosci       Date:  2009-06-27       Impact factor: 1.961

3.  Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats.

Authors:  D Wöhrle; U Salat; D Gläser; J Mücke; M Meisel-Stosiek; D Schindler; W Vogel; P Steinbach
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

4.  FMRP expression as a potential prognostic indicator in fragile X syndrome.

Authors:  F Tassone; R J Hagerman; D N Iklé; P N Dyer; M Lampe; R Willemsen; B A Oostra; A K Taylor
Journal:  Am J Med Genet       Date:  1999-05-28

5.  Clinical screening score for the fragile X (Martin-Bell) syndrome.

Authors:  S Laing; M Partington; H Robinson; G Turner
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

6.  Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males.

Authors:  A M Lachiewicz; D V Dawson; G A Spiridigliozzi
Journal:  Am J Med Genet       Date:  2000-06-05

7.  Fragile X syndrome in a normal IQ male with learning and emotional problems.

Authors:  S A Merenstein; V Shyu; W E Sobesky; L Staley; E Berry-Kravis; D L Nelson; K A Lugenbeel; A K Taylor; B F Pennington; R J Hagerman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Nov-Dec       Impact factor: 8.829

8.  Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations.

Authors:  Elisabetta Tabolacci; Umberto Moscato; Francesca Zalfa; Claudia Bagni; Pietro Chiurazzi; Giovanni Neri
Journal:  Eur J Hum Genet       Date:  2008-07-16       Impact factor: 4.246

9.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

Review 10.  Neurodevelopmental disorders and genetic testing: current approaches and future advances.

Authors:  Elliott H Sherr; David J Michelson; Michael I Shevell; John B Moeschler; Andrea L Gropman; Stephen Ashwal
Journal:  Ann Neurol       Date:  2013-08       Impact factor: 11.274

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.